COVID-19 and Cancer Consortium Registry

Study summary

In this study we will collect granular information on cancer patients infected with COVID-19, as rapidly as possible. The mechanism for collection of this information is a de-identified centralized registry housed at Vanderbilt University Medical Center, with data donations from internal and external health care professionals.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedWeb-based REDCap survey

The study team can explain what participation involves.

Who it may be forCOVID-19 · Invasive Malignancy (Any Type)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 9, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Vanderbilt-Ingram Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Vanderbilt-Ingram Cancer Center
Interventions being studied: Other: Web-based REDCap survey

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Healthcare providers or their proxies who would like to report a patient with ALL of the following criteria:
Suspected (presumptive positive based on clinical presentation) or lab-confirmed COVID-19.
Current or past medical history of invasive malignancy (any type)

Reasons someone may not be able to joinExclusion criteria

Participants at international sites not explicitly listed below
Non-healthcare providers (or their proxies)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Vanderbilt University Medical CenterNashville, Tennessee

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 9, 2024. Always confirm current availability with the study team.

View original record ↗